TACC3 as an independent prognostic marker for solid tumors: a systematic review and meta-analysis

Abstract

Recent studies have showed that the transforming acidic coiled coil 3 (TACC3), was aberrantly up-regulated in various solid tumors and was reported to be correlated with unfavorable prognosis in cancer patients. This study aimed to examine the relationship between TACC3 and relevant clinical outcomes. Pubmed, Web of Science, Embase and Cochrane Library were systematically searched to obtain all eligible articles. Pooled hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated to evaluate the influence of TACC3 expression on overall survival (OS) and disease-free survival (DFS) in solid tumors patients. A total of 1943 patients from 11 articles were included. The result indicated that a significantly shorter OS was observed in patients with high expression level of TACC3 (HR=1.90, 95% CI=1.63–2.23). In the subgroup analysis, the association was also observed in patients with cancers of digestive system (HR=1.85, 95% CI=1.53–2.24). Statistical significance was also observed in subgroup meta-analysis stratified by the cancer type, analysis type and sample size. Furthermore, poorer DFS was observed in patients with high expression level of TACC3 (HR=2.67, 95% CI=2.10–3.40). Additionally, the pooled odds ratios (ORs) showed that increased TACC3 expression was also related to positive lymph node metastasis (OR=1.68, 95% CI=1.26–2.25), tumor differentiation (OR=1.90, 95% CI=1.25–2.88) and TNM stage (OR=1.66, 95% CI=1.25-2.20). In conclusion, the increased expression level of TACC3 was associated with unfavorable prognosis, suggesting that it was a valuable prognosis biomarker or a promising therapeutic target of solid tumors. Further studies should be conducted to confirm the clinical utility of TACC3 in human solid tumors.

Transforming acidic coiled-coil protein-3: a novel marker for differential diagnosis and prognosis prediction in endocervical adenocarcinoma

“…Abnormal expression of TACC3 is detected in human malignancies, and its role has been extensively investigated (Wang 2017a ). TACC3 is overexpressed in human malignancies and has oncogenicproperties (Wang 2017a ). In addition, TACC3 overexpression is associated with a dismal prognostic outcome (Song 2018 ; Nahm 2016 ; Li 2017 ).…”

“…To our knowledge, the present work is the first to reveal the clinical implication pf TACC3 in ECA. Abnormal expression of TACC3 is detected in human malignancies, and its role has been extensively investigated (Wang 2017a). TACC3 is overexpressed in human malignancies and has oncogenicproperties (Wang 2017a).…”

Transforming Acidic Coiled-coil Protein-3: A Novel Marker for Differential Diagnosis and Prognosis Prediction in Endocervical Adenocarcinoma

“…The abnormal TACC3 expression is detected in human malignancies, and its role has been extensively investigated (Wang et al,2017). TACC3 is over-expressed in human malignancies and demonstrates the oncogenic property (Wang et al,2017).…”

“…The abnormal TACC3 expression is detected in human malignancies, and its role has been extensively investigated (Wang et al,2017). TACC3 is over-expressed in human malignancies and demonstrates the oncogenic property (Wang et al,2017). In addition, TACC3 over-expression is identi ed to be related to dismal prognostic outcome (Song et al,2018, Li et al,2017, Nahm et al,2016.…”

The cell cycle state defines TACC3 as a regulator gene in glioblastoma

“…Elevated expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) has been associated with adverse patient outcomes in a wide range of different cancers including brain, breast, and lung (1). Following the first functional characterization of TACC3 in vivo (2), an everincreasing number of studies implicate the expression of TACC3 (3)(4)(5)(6)(7)(8) and/or TACC3 fusion proteins (e.g., TACC3-FGFR3; (9)) in tumor growth.…”